IL-31 is crucial for induction of pruritus, but not inflammation, in contact hypersensitivity

[1]  T. Ruzicka,et al.  Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis. , 2017, The New England journal of medicine.

[2]  H. Hermanns.  Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology. , 2015, Cytokine & growth factor reviews.

[3]  N. Yamashita,et al.  Anti‐IL‐31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice , 2014, British journal of pharmacology.

[4]  K. Hartmann,et al.  Interleukin-31: A Novel Diagnostic Marker of Allergic Diseases , 2014, Current Allergy and Asthma Reports.

[5]  T. Buhl,et al.  A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1. , 2014, The Journal of allergy and clinical immunology.

[6]  M. Wagenmann,et al.  The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptoms , 2012, Clinical and Translational Allergy.

[7]  Gernot Posselt,et al.  Dendritic Cells Activated by IFN-γ/STAT1 Express IL-31 Receptor and Release Proinflammatory Mediators upon IL-31 Treatment , 2012, The Journal of Immunology.

[8]  B. Igyártó,et al.  Early immune events in the induction of allergic contact dermatitis , 2012, Nature Reviews Immunology.

[9]  A. Kim,et al.  Ultraviolet B radiation and reactive oxygen species modulate interleukin‐31 expression in T lymphocytes, monocytes and dendritic cells , 2011, The British journal of dermatology.

[10]  S. Dillon,et al.  IL-31 Receptor (IL-31RA) Knockout Mice Exhibit Elevated Responsiveness to Oncostatin M , 2010, The Journal of Immunology.

[11]  T. Abe,et al.  IL-33 is a crucial amplifier of innate rather than acquired immunity , 2010, Proceedings of the National Academy of Sciences.

[12]  I. Nagaoka,et al.  Antimicrobial Peptides Human β-Defensins and Cathelicidin LL-37 Induce the Secretion of a Pruritogenic Cytokine IL-31 by Human Mast Cells , 2010, The Journal of Immunology.

[13]  T. Werfel,et al.  Interleukin (IL)‐31 induces pro‐inflammatory cytokines in human monocytes and macrophages following stimulation with staphylococcal exotoxins , 2009, Allergy.

[14]  R. Hoffman,et al.  Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders. , 2009, Blood.

[15]  K. Matsushima,et al.  Anti‐interleukin‐31‐antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis , 2009, Experimental dermatology.

[16]  S. Ständer,et al.  Correlation of IL-31 serum levels with severity of atopic dermatitis. , 2008, The Journal of allergy and clinical immunology.

[17]  Z. Lei,et al.  Original article: SCF and IL‐31 rather than IL‐17 and BAFF are potential indicators in patients with allergic asthma , 2007, Allergy.

[18]  S. Nakae,et al.  Th17 and allergy. , 2008, Allergology international : official journal of the Japanese Society of Allergology.

[19]  C. Wong,et al.  Interleukin‐31 induces cytokine and chemokine production from human bronchial epithelial cells through activation of mitogen‐activated protein kinase signalling pathways: implications for the allergic response , 2007, Immunology.

[20]  S. Brand,et al.  Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease , 2007, Gut.

[21]  E. Pearce,et al.  IL-31–IL-31R interactions negatively regulate type 2 inflammation in the lung , 2007, The Journal of experimental medicine.

[22]  A. Bosio,et al.  Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. , 2006, The Journal of allergy and clinical immunology.

[23]  M. Tsai,et al.  Mast Cell-Associated TNF Promotes Dendritic Cell Migration1 , 2006, The Journal of Immunology.

[24]  M. Steinhoff,et al.  IL-31: a new link between T cells and pruritus in atopic skin inflammation. , 2006, The Journal of allergy and clinical immunology.

[25]  S. Nakaike,et al.  Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis. , 2005, European journal of pharmacology.

[26]  Scott R. Presnell,et al.  Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice , 2004, Nature Immunology.

[27]  S. Akira,et al.  Signal Transducer and Activator of Transcription 6 Is Essential in the Induction of Contact Hypersensitivity , 2000, The Journal of experimental medicine.

[28]  T. Krieg,et al.  Inhibition of allergic contact dermatitis to DNCB but not to oxazolone in interleukin-4-deficient mice. , 1999, The Journal of investigative dermatology.

[29]  A. Reske-Kunz,et al.  Diminished Contact Hypersensitivity Response in IL‐4 Deficient Mice at a Late Phase of the Elicitation Reaction , 1997, Scandinavian journal of immunology.